| __timestamp | Catalyst Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 20140000 |
| Thursday, January 1, 2015 | 8597010 | 37173000 |
| Friday, January 1, 2016 | 7910260 | 48616000 |
| Sunday, January 1, 2017 | 7304399 | 108488000 |
| Monday, January 1, 2018 | 15875961 | 244622000 |
| Tuesday, January 1, 2019 | 36881187 | 287000000 |
| Wednesday, January 1, 2020 | 44233754 | 354000000 |
| Friday, January 1, 2021 | 49628000 | 186000000 |
| Saturday, January 1, 2022 | 58183000 | 151000000 |
| Sunday, January 1, 2023 | 133710000 | 232600000 |
| Monday, January 1, 2024 | 267474000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Ionis Pharmaceuticals, Inc. and Catalyst Pharmaceuticals, Inc. have shown contrasting approaches to handling these costs. From 2014 to 2023, Ionis consistently reported higher SG&A expenses, peaking at approximately $232 million in 2023. In contrast, Catalyst's expenses, although significantly lower, surged by nearly 2,900% from 2014 to 2023, reaching around $134 million.
This trend highlights Ionis's larger scale of operations, but also raises questions about Catalyst's rapid increase in costs. While Ionis's expenses have fluctuated, Catalyst's steady rise suggests a strategic expansion. Investors and industry analysts should consider these trends when evaluating the financial health and strategic direction of these companies.
Novo Nordisk A/S and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Catalyst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Intra-Cellular Therapies, Inc. or Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Blueprint Medicines Corporation and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.: SG&A Spending Patterns Compared